173 related articles for article (PubMed ID: 9154658)
1. Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome.
Sierra RI; Specker BL; Jiménez F; Cruz C; Pedraza-Chaverrí J
Ren Fail; 1997 May; 19(3):409-24. PubMed ID: 9154658
[TBL] [Abstract][Full Text] [Related]
2. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
[TBL] [Abstract][Full Text] [Related]
3. Time course analysis of serum and urinary proteins by SDS-PAGE in experimental nephrotic syndrome.
Pedraza-Chaverrí J; Sosa G; Cruz C; Medina-Campos ON; Ibarra-Rubio ME
Ren Fail; 1996 Mar; 18(2):181-94. PubMed ID: 8723356
[TBL] [Abstract][Full Text] [Related]
4. Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome.
Pedraza-Chaverrí J; Torres-Rodríguez GA; Cruz C; Mainero A; Tapia E; Ibarra-Rubio ME; Silencio JL
Nephron; 1994; 66(1):87-92. PubMed ID: 8107960
[TBL] [Abstract][Full Text] [Related]
5. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
6. Effects of treadmill exercise on bone mass, bone metabolism, and calciotropic hormones in young growing rats.
Iwamoto J; Shimamura C; Takeda T; Abe H; Ichimura S; Sato Y; Toyama Y
J Bone Miner Metab; 2004; 22(1):26-31. PubMed ID: 14691683
[TBL] [Abstract][Full Text] [Related]
7. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
[TBL] [Abstract][Full Text] [Related]
8. Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats.
Shao P; Ohtsuka-Isoya M; Shinoda H
Chronobiol Int; 2003 Mar; 20(2):325-36. PubMed ID: 12723888
[TBL] [Abstract][Full Text] [Related]
9. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome.
Koşan C; Ayar G; Orbak Z
West Indian Med J; 2012 Sep; 61(6):627-30. PubMed ID: 23441359
[TBL] [Abstract][Full Text] [Related]
10. Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome.
Pedraza-Chaverri J; Cruz C; Tapia E; Peña JC
Ren Fail; 1992; 14(4):523-31. PubMed ID: 1462003
[TBL] [Abstract][Full Text] [Related]
11. Effect of thyroid hormone on bone and mineral metabolism in rat: evaluation by biochemical markers.
Ishihara C; Kushida K; Takahashi M; Koyama S; Kawana K; Atsumi K; Inoue T
Endocr Res; 1997 Aug; 23(3):167-80. PubMed ID: 9378104
[TBL] [Abstract][Full Text] [Related]
12. Effect of taurine feeding on bone mineral density and bone markers in rats.
Choi MJ; Seo JN
Adv Exp Med Biol; 2013; 776():51-8. PubMed ID: 23392870
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Biochemical Bone Turnover Markers and Bone Mineral Density in Thin and Normal-Weight Children.
Ambroszkiewicz J; Gajewska J; Rowicka G; Klemarczyk W; Chelchowska M
Cartilage; 2018 Jul; 9(3):255-262. PubMed ID: 29156943
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome.
Arévalo AE; Ibarra-Rubio ME; Cruz C; Peńa JC; Pedraza-Chaverrí J
Clin Chim Acta; 1990 Nov; 191(3):175-84. PubMed ID: 2175683
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
Terzi T; Terzi M; Tander B; Cantürk F; Onar M
J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy.
Siomou E; Challa A; Tzoufi M; Papadopoulou ZL; Lapatsanis PD; Siamopoulou A
Calcif Tissue Int; 2003 Oct; 73(4):319-25. PubMed ID: 12874699
[TBL] [Abstract][Full Text] [Related]
17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
18. In vivo microvascular clearance of albumin in renal and extrarenal tissues in puromycin aminonucleoside (PAN) induced nephrotic syndrome.
Oqvist BW; Rippe A; Tencer J; Rippe B
Nephrol Dial Transplant; 1999 Aug; 14(8):1898-903. PubMed ID: 10462268
[TBL] [Abstract][Full Text] [Related]
19. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
20. Effect of zinc supplementation on bone metabolism in male rats chronically exposed to cadmium.
Brzóska MM; Rogalska J; Galażyn-Sidorczuk M; Jurczuk M; Roszczenko A; Kulikowska-Karpińska E; Moniuszko-Jakoniuk J
Toxicology; 2007 Jul; 237(1-3):89-103. PubMed ID: 17560002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
